Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation.

To the editor: Chronic graft-versus-host disease (cGVHD) is an allo-immune reaction against recipient organs after allogeneic hematopoietic stem cell transplantation (AHSCT).[1][1] Clinical forms of skin cGVHD are mainly described as lichenoid and sclerodermatous.[2][2][⇓][3]-[4][4] Localized

[1]  B. Sandmaier,et al.  Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. , 2013, Blood.

[2]  M. Rybojad,et al.  Acute and chronic skin graft-versus-host disease--pathophysiological aspects. , 2012, Current problems in dermatology.

[3]  E. Holler,et al.  Graft-versus-host disease , 2009, The Lancet.

[4]  A. Gratwohl,et al.  Vascular endothelium as 'novel' target of graft-versus-host disease. , 2008, Best practice & research. Clinical haematology.

[5]  J. McNiff,et al.  Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. , 2005, Journal of the American Academy of Dermatology.

[6]  J. Pober,et al.  Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease , 2002, The Lancet.

[7]  R. Anderson,et al.  Eosinophilic fasciitis presenting as pitting edema of the extremities. , 2001, The American journal of medicine.

[8]  I. Wicks,et al.  Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation. , 2001, Arthritis and rheumatism.

[9]  J. Hara,et al.  Serum levels of soluble adhesion molecules in stem cell transplantation-related complications , 2001, Bone Marrow Transplantation.

[10]  K. Yamane,et al.  Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma. , 2000, Journal of the American Academy of Dermatology.